Auclair Karine, Polic Vanja
Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montreal, Quebec, H3A0B8, Canada,
Adv Exp Med Biol. 2015;851:209-28. doi: 10.1007/978-3-319-16009-2_8.
Cytochrome P450 enzymes (P450s) have the ability to oxidize unactivated C-H bonds of substrates with remarkable regio- and stereoselectivity. Comparable selectivity for chemical oxidizing agents is typically difficult to achieve. Hence, there is an interest in exploiting P450s as potential biocatalysts. Despite their impressive attributes, the current use of P450s as biocatalysts is limited. While bacterial P450 enzymes typically show higher activity, they tend to be highly selective for one or a few substrates. On the other hand, mammalian P450s, especially the drug-metabolizing enzymes, display astonishing substrate promiscuity. However, product prediction continues to be challenging. This review discusses the use of small molecules for controlling P450 substrate specificity and product selectivity. The focus will be on two approaches in the area: (1) the use of decoy molecules, and (2) the application of substrate engineering to control oxidation by the enzyme.
细胞色素P450酶(P450s)能够以显著的区域和立体选择性氧化底物中未活化的碳氢键。对于化学氧化剂而言,通常难以实现类似的选择性。因此,人们对利用P450s作为潜在的生物催化剂很感兴趣。尽管P450s具有令人印象深刻的特性,但目前将其用作生物催化剂的应用仍然有限。虽然细菌P450酶通常表现出较高的活性,但它们往往对一种或几种底物具有高度选择性。另一方面,哺乳动物P450s,尤其是药物代谢酶,表现出惊人的底物混杂性。然而,产物预测仍然具有挑战性。本综述讨论了使用小分子来控制P450底物特异性和产物选择性。重点将放在该领域的两种方法上:(1)使用诱饵分子,以及(2)应用底物工程来控制酶的氧化作用。